Table 1.
Baseline characteristics of the patients with assessable ejaculation 12 weeks after intervention.
| Characteristica | PAE (N = 25) | TURP (N = 25) |
|---|---|---|
| Age, years | 62.9 ± 7.5 | 63.1 ± 9.0 |
| Body-mass-index, kg m−2 | 25.8 ± 3.5 | 26.8 ± 3.2 |
| Charlson comorbidity index | 3.2 ± 1.2 | 4.0 ± 2.1 |
| Prostate volume (transabdominal ultrasound), mL | 50.6 ± 16.3 | 52.1 ± 20.1 |
| Prostate volume (magnetic resonance imaging), mL | 49.8 ± 31.8 | 59.7 ± 35.3 |
| Medical treatment of LUTS prior to surgery, no. (%) | ||
| 5-Alpha-reductase inhibitors alone | 0 (0%) | 0 (0%) |
| Alpha1-adrenergic receptor antagonists | 12 (48%) | 12 (48%) |
| Combination of the two above | 7 (28%) | 4 (16%) |
| Total patients with drug treatment | 19 (76%) | 16 (64%) |
| Indwelling urethral catheter at baseline, no. (%) | 4 (16%) | 3 (12%) |
aNumeric data are summarized as mean ± standard deviation and categorical data as number and percentage